arrow
F

François Provôt

CHU de Lille
H指数:40
被引数:7,193

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-time, multidisciplinary approach of women with pregnancy-associated thrombotic microangiopathy

妊娠相关性血栓性微血管病女性的实时、多学科方法

2026-06-180
OAAI
Donor Characteristics Associated With Graft Loss and Delayed Graft Function in Very-Aged Kidney Donors: An Observational Multicentric Study

与移植物丢失和延迟移植物功能相关的非常高龄肾捐献者特征:一项观察性多中心研究

2025-11-180
OA
Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura

优化ADAMTS13预防治疗以减少先天性血栓性血小板减少性紫癜的复发和器官衰竭

2025-09-010
OAAI
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome in adult kidney transplant recipients

志贺毒素产生性大肠杆菌相关的成人肾移植受者溶血尿毒症综合征

2025-08-110
OAAI
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP

抗ADAMTS13抗体轨迹与免疫介导性TTP中ADAMTS13恢复相关

2025-07-150
OAAI
Progressive Multifocal Leukoencephalopathy in Kidney Transplant Recipients: A Retrospective Multicenter Nationwide Case Series

进行性多灶性白质脑病在肾移植受者中的发生:一项全国多中心回顾性病例系列研究

2025-04-220
PRE
Association between HOMA2 based beta-cell function or insulin resistance and long-term outcomes in kidney transplant recipients with type 2 diabetes

基于HOMA2的 β 细胞功能或胰岛素抵抗与2型糖尿病肾移植受者长期预后的关系

2024-12-300
OAAI
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Obinutuzumab治疗免疫介导的血栓性血小板减少性紫癜的疗效和安全性

2024-12-120
OAAI
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft

移植前抗nephrin抗体是同种异体肾移植中复发性弥漫性足细胞病的特异性预测指标

2024-10-012
PRE
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN
2023-08-248
PRE
Post-traumatic stress disorder and quality of life alterations in survivors of immune-mediated thrombotic thrombocytopenic purpura and atypical hemolytic and uremic syndrome
2023-08-015
OAAI